English
Home > Products > CAS NO 101020-79-5

China CAS NO 101020-79-5 Factory

We also present product or service sourcing and flight consolidation products and services. We have our possess manufacturing facility and sourcing place of work. We can easily supply you with almost every type of product or service connected to our item variety for CAS NO 101020-79-5,101020-79-5,Ademetionine 1,4-butanedisulfonate,1,4-butanedisulfonate, We'll make larger endeavours to assist domestic and international prospective buyers, and make the mutual advantage and win-win partnership between us. we are eagerly waiting for your sincerely cooperation.
CAS NO 101020-79-5, We're sticking to excellent quality, competitive price and punctual delivery and better service, and sincerely hope to establish long-term good relationships and cooperation with our new and old business partners from all over the world. Sincerely welcome you to join us.

Related Products

Hot Products

  • (4R)-4-Aminopentanoic acid

    (4R)-4-Aminopentanoic acid

    Product Name:(4R)-4-Aminopentanoic acid
    Molecular Formula:C5H11NO2
    Molecular Weight:117.15
    CAS Registry Number:5937-83-7
  • LEE011

    LEE011

    Product Name:LEE011
    Molecular Formula:C22H29ClN8
    Molecular Weight;440.97
    CAS Registry Number;1256963-02-6
  • Agomelatine

    Agomelatine

    Product Name:Agomelatine
    Molecular Formula:C15H17NO2
    Molecular Weight;243.3
    CAS Registry Number;138112-76-2
  • Apalutamide

    Apalutamide

    Product Name:Apalutamide
    Molecular Formula:C21H15F4N5O2S
    Molecular Weight;477.43
    CAS Registry Number;956104-40-8
  • Salbutamol

    Salbutamol

    Product Name:Salbutamol
    Molecular Formula:C13H21NO3
    Molecular Weight;239.31
    CAS Registry Number;34391-04-3
  • Ammonium dihydrogen phosphate

    Ammonium dihydrogen phosphate

    Product Name:Ammonium dihydrogen phosphate
    Molecular Formula:H6NO4P
    Molecular Weight:115.03
    CAS Registry Number:7722-76-1
  • Related Blog
  • Reviews

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept